[Serum prolactin concentration in children with celiac disease]

U Gocyła1, Z Szczepański, B Kalita

  • 1III Katedra i Klinika Pediatrii Slaskiej Akademii Medyeznej w Bytomiu.

Pediatria Polska
|September 1, 1996
PubMed

Insights

Serum prolactin levels are elevated in children with celiac disease not adhering to a gluten-free diet. Prolactin concentrations normalize with adherence to a gluten-free diet, indicating its role in celiac disease management.

Area of Science:

  • Pediatric Gastroenterology
  • Endocrinology
  • Immunology

Background:

  • Celiac disease is an autoimmune disorder triggered by gluten ingestion.
  • Altered hormone levels, including prolactin, have been observed in various autoimmune conditions.
  • The role of prolactin in pediatric celiac disease requires further elucidation.

Purpose of the Study:

  • To investigate serum prolactin concentrations in children diagnosed with celiac disease.
  • To compare prolactin levels between celiac patients on and off a gluten-free diet (GFD).
  • To assess the correlation between prolactin levels and the severity of intestinal mucosal lesions.

Main Methods:

  • Radioimmunoassay (RIA) was utilized to measure serum prolactin levels.
  • The study included 62 children (4-15 years) with celiac disease and 30 healthy controls.
  • Small bowel mucosal biopsies were performed to assess the degree of mucosal damage.

Main Results:

  • Children with celiac disease not on a GFD exhibited significantly higher serum prolactin concentrations compared to controls.
  • The highest prolactin levels were observed in patients with severe mucosal lesions.
  • No significant difference in prolactin levels was found between celiac patients on a GFD and the control group.

Conclusions:

  • Elevated serum prolactin is associated with active celiac disease in children.
  • A gluten-free diet appears to normalize prolactin levels in pediatric celiac disease patients.
  • Prolactin may serve as a potential biomarker or indicator of disease activity in celiac disease.